An anti-inflammatory diet produces measurable changes in circulating blood markers, specifically high-sensitivity C-reactive protein (hs-CRP). At Longevity Benchmark, we separate what clinical research supports from marketing claims about wellness foods. In the PREvención con DIeta MEDiterránea (PREDIMED) randomized controlled trial, participants assigned to Mediterranean diet groups saw reductions of 16% or more in plasma hs-CRP concentrations at 3 and 5 years.
The Verdict
What Moves, And By How Much
The primary inflammatory blood marker that shifts in clinical dietary trials is high-sensitivity C-reactive protein (hs-CRP). In the PREDIMED randomized controlled trial, both Mediterranean diet intervention groups achieved reductions of 16% or more in plasma hs-CRP concentrations after 3 and 5 years.
This reduction persisted over time. It did not require total elimination of major food categories. Popular wellness guides often describe an anti-inflammatory diet as an all-encompassing lifestyle overhaul. The trials used a blood draw, and our guide to inflammation blood tests covers which markers they read.
The trial records show something far more specific. Participants followed a traditional Mediterranean pattern, and their systemic inflammation dropped over multi-year follow-up periods. Blood draws at year 3 and year 5 confirmed that the reduction was durable over multiple years.
The Olive Oil And Nuts Split
A pilot study within PREDIMED demonstrated that different components of the Mediterranean diet produce unequal effects on inflammatory blood markers. In this 3-month intervention, researchers compared Mediterranean diet patterns against a low-fat control diet. Both Mediterranean diet arms reduced interleukin-6 (IL-6) and vascular adhesion molecules compared to the control group.
Plasma hs-CRP fell only when the Mediterranean diet was supplemented with polyphenol-rich extra-virgin olive oil. In the arm supplemented with nuts, hs-CRP did not decrease.
Both arms consumed nutritious whole foods, but only the polyphenol-rich oil moved hs-CRP. Many online resources group all anti-inflammatory foods together into single recommendations. The pilot trial indicates that polyphenol-rich fats carry the measurable effect on hs-CRP.
A 2026 ancillary analysis of the Walnuts and Healthy Aging trial is sometimes read as overturning this. It does not. That analysis found a 0.64-point difference in the Dietary Inflammatory Index between daily walnut eaters and controls, and the Dietary Inflammatory Index is a score computed from reported food intake rather than a measurement taken from blood. The PREDIMED finding on hs-CRP above is a blood result, so the two sit a step apart and neither contradicts the other.
Trial Evidence Versus Cohort Evidence
The ATTICA study and a US nurses cohort report similar drops in inflammatory markers, and neither design can establish cause and effect. In the ATTICA study, researchers evaluated Mediterranean diet adherence across an observational cohort. Participants in the highest tertile of adherence had 20% lower levels of hs-CRP, 17% lower interleukin-6, and 14% lower white blood cell counts.
These findings represent population correlations rather than randomized trial interventions. Data from a large US nurses cohort revealed similar associations. In that population, higher adherence to a Mediterranean dietary pattern was linked to 24% lower hs-CRP concentrations. Researchers also documented 16% lower IL-6 and 13% lower E-selectin concentrations.
Observational cohorts record what people were already eating. PREDIMED assigned the diet. The cohort percentages here run slightly larger than the trial's, and nothing on this page explains why.
| Study or Cohort | Study Design | Inflammatory Biomarkers Measured | Reported Difference or Reduction |
|---|---|---|---|
| PREDIMED (Long-term) | Randomized controlled trial | Plasma hs-CRP | 16% or greater reduction at 3 and 5 years |
| PREDIMED (3-month pilot) | Randomized controlled trial | hs-CRP, IL-6, adhesion molecules | hs-CRP fell with extra-virgin olive oil, not nuts; IL-6 and adhesion molecules fell in both |
| ATTICA study | Observational population cohort | hs-CRP, IL-6, white blood cells | 20% lower hs-CRP, 17% lower IL-6, 14% lower white blood cells in top tertile |
| US nurses cohort | Observational prospective cohort | hs-CRP, IL-6, E-selectin | 24% lower hs-CRP, 16% lower IL-6, 13% lower E-selectin with higher adherence |
The Dose-Response Signal
Clinical research indicates that the magnitude of biomarker reduction corresponds directly to dietary polyphenol intake. In a PREDIMED substudy led by Medina-Remon and colleagues, researchers evaluated 1,139 high-risk participants.
The team identified a dose-dependent anti-inflammatory effect of polyphenols across the analyzed population. Higher intake produced greater biomarker changes. Participants with the highest polyphenol intake experienced the greatest reductions in circulating plasma inflammatory biomarkers.
This dose-dependent relationship reinforces the pilot study findings regarding extra-virgin olive oil. The evidence behind this page carries no polyphenol content for any food. It carries the trial's own label for that arm, and that label is polyphenol-rich extra-virgin olive oil. The data suggest that total polyphenol quantity influences measurable inflammatory outcomes.
What A Fifteen Percent Event Reduction Tells You About Scale
In the CANTOS trial, researchers tested canakinumab. That pharmaceutical trial achieved a 15% relative reduction in major cardiovascular events.
Dietary trials do not match targeted drugs. The CANTOS result puts a number on what lowering inflammation was worth.
In PREDIMED, Mediterranean diets supplemented with polyphenol-rich oil lowered plasma hs-CRP by 16% or more over 3 and 5 years. A 16% drop in a biomarker reflects real biological movement. Yet biomarker changes do not guarantee an identical reduction in clinical events. Inflammation represents one component of vascular health alongside lipids, blood glucose, and blood pressure.
Why This Pattern Is Testable And A Food List Is Not
A dietary pattern is clinically verifiable only when attached to an objective circulating biomarker like high-sensitivity C-reactive protein. Broad claims about wellness diets remain difficult to evaluate if no specific blood marker is measured. In clinical trials, researchers did not rely on subjective surveys. They measured blood levels.
Standard lab testing measures plasma hs-CRP with high precision, as covered in our guide to hs-CRP testing. When an individual adopts an anti-inflammatory diet, objective testing shows whether baseline inflammation shifted.
A later reading only means something against a first one. This page does not set a cutoff for hs-CRP, because the reference range that applies is the one printed on the report.
Our review of normal versus optimal ranges explains how clinical reference intervals differ from preventive targets. Other emerging markers, such as those in our analysis of hs-CRP versus glycans, assess chronic inflammation across separate pathways. What the trials measured for a different dietary question is covered in our guide on foods to lower cholesterol.
Who Should Not Expect Much From This
Dietary adjustments do not produce meaningful biomarker changes for every individual or clinical situation. The participants in clinical trials like PREDIMED were selected based on specific cardiovascular risk profiles, meaning their baseline biology had room to shift. Certain clinical presentations fall outside these trial findings:
- Anyone whose hs-CRP already sits at the low end of their lab range. PREDIMED enrolled people at high cardiovascular risk, and the 16% figure is theirs. Nothing on this page reports what happens to an hs-CRP that is already at the low end of its range, and our guide to normal versus optimal ranges explains which range applies.
- People with acute infections or recent injuries. A sharp spike in CRP often reflects temporary tissue damage, surgical recovery, or acute infection rather than baseline nutrition. As explained in our guide to high CRP levels, an infection or injury moves CRP far more than a diet does, so a draw taken during one tells you about the illness instead.
- Patients seeking treatment for diagnosed autoimmune or inflammatory diseases. Rheumatoid arthritis, inflammatory bowel disease, and other diagnosed inflammatory conditions require targeted medical therapies overseen by a physician. Nutritional patterns do not replace pharmacological care, and patients can review comprehensive inflammation blood tests with their medical team.
What Would Change This Assessment
Our assessment of an anti-inflammatory diet rests on published randomized trial data and observational cohorts, but several unresolved questions could modify these conclusions. Scientific understanding shifts when rigorous new trials isolate variables that previous studies bundled together. Three specific clinical developments would alter this evaluation:
- A randomized trial isolating polyphenols from dietary fats. Current data compare extra-virgin olive oil against nuts or low-fat controls. A trial testing polyphenol extracts against matched dietary fatty acids would confirm whether polyphenols alone or the fatty acid matrix drive biomarker reductions.
- Replication studies showing consistent hs-CRP reduction from nuts. The PREDIMED pilot study found no reduction in hs-CRP from nut supplementation over 3 months. If a larger randomized trial demonstrates that nut consumption independently lowers hs-CRP, our conclusion regarding the olive oil split would require revision.
- Direct outcome trials proving that diet-induced hs-CRP drops reduce events. While the CANTOS trial demonstrated that reducing inflammation with medication lowers cardiovascular events by 15%, no clinical trial has proven that the 16% hs-CRP reduction achieved through dietary modifications yields an equivalent hard endpoint reduction.
If you want to know whether a change in how you eat did anything measurable, hs-CRP is the marker these trials used, and our hs-CRP guide explains what a single draw can and cannot tell you.
Frequently Asked Questions
Does an anti-inflammatory diet actually lower inflammation?
Yes, clinical trials confirm that an anti-inflammatory diet lowers circulating inflammatory markers, particularly high-sensitivity C-reactive protein (hs-CRP). In the PREDIMED randomized controlled trial, participants following a Mediterranean dietary pattern achieved reductions of 16% or more in plasma hs-CRP at 3 and 5 years compared to their baselines. A 3-month pilot study also documented reductions in interleukin-6 (IL-6) and vascular adhesion molecules. Observational cohorts, including the ATTICA study and a large US nurses cohort, similarly associate Mediterranean diet adherence with 20% to 24% lower hs-CRP levels. The evidence demonstrates measurable biological shifts, though the effect depends heavily on specific dietary components rather than general food categories.
How much does the Mediterranean diet lower CRP?
In the randomized PREDIMED trial, both Mediterranean diet groups achieved reductions of 16% or more in plasma hs-CRP concentrations over 3 and 5 years. Observational cohorts report comparable or slightly larger associations. For example, the ATTICA study found that individuals in the highest tertile of Mediterranean diet adherence had 20% lower hs-CRP levels than those in the lowest tertile. Similarly, a cohort of US nurses found that higher adherence was associated with a 24% reduction in hs-CRP concentrations. While observational figures reflect long-term self-selected lifestyles, the 16% reduction in PREDIMED represents that figure from a randomized intervention.
How long does it take for diet to lower CRP?
Published clinical trial data document measurable reductions in hs-CRP across specific timepoints: a 3-month pilot phase and long-term follow-ups at 3 and 5 years. In the PREDIMED pilot study, researchers recorded significant reductions in hs-CRP, interleukin-6, and adhesion molecules after 3 months of dietary intervention, though the hs-CRP reduction occurred only with extra-virgin olive oil supplementation. In the full trial, sustained hs-CRP reductions of 16% or more were confirmed at 3-year and 5-year blood draws. Clinical trials have not established intermediate timepoints such as 2 weeks or 6 weeks, so no shorter interval appears here.
Which part of the Mediterranean diet lowers inflammation?
Evidence from the PREDIMED trial points specifically to polyphenol-rich extra-virgin olive oil as the primary driver of hs-CRP reductions. In the trial's 3-month pilot study, hs-CRP decreased significantly only in the arm supplemented with extra-virgin olive oil, while the arm supplemented with nuts showed no reduction. A subsequent substudy of 1,139 participants led by Medina-Remon confirmed a dose-dependent anti-inflammatory effect directly linked to total polyphenol intake. While both nuts and olive oil reduced other inflammatory markers like interleukin-6 and adhesion molecules, moving hs-CRP required the polyphenol-rich fat.
Do nuts lower CRP?
In the PREDIMED pilot trial, nuts did not lower hs-CRP. The 3-month intervention compared a Mediterranean diet supplemented with nuts against a Mediterranean diet supplemented with extra-virgin olive oil and a low-fat control diet. While the nut-supplemented group achieved reductions in interleukin-6 and vascular adhesion molecules, plasma hs-CRP concentrations did not decrease. This finding contrasts with popular claims that all healthy fats and nuts reduce general inflammation equally. Nuts provide nutritional value and reduce other vascular markers, but clinical trial evidence does not support the claim that they lower circulating hs-CRP.
Is hs-CRP the best way to track an anti-inflammatory diet?
High-sensitivity C-reactive protein (hs-CRP) is the primary inflammatory marker used in randomized dietary trials, making it the most clinically validated way to assess dietary shifts. Standard lab tests measure hs-CRP accurately, and an acute illness or injury moves CRP far more than diet does, as our guide to high CRP levels sets out. Other research markers, such as interleukin-6 and adhesion molecules, also respond to dietary changes but are rarely ordered on routine clinical panels. hs-CRP is the marker these trials used, and that is why the claim is checkable at all. Whether and when anyone measures it is a clinical decision, not one this page makes.
What is the difference between the trial evidence and the observational evidence here?
Randomized controlled trials like PREDIMED assign participants to specific dietary interventions, establishing direct cause-and-effect relationships between food intake and inflammatory biomarkers over 3 months, 3 years, and 5 years. Observational cohorts, such as the ATTICA study and the US nurses cohort, observe existing eating habits across large populations without intervention. Both report that higher Mediterranean diet adherence tracks with 20% to 24% lower hs-CRP and 16% to 17% lower IL-6, and neither can rule out confounding lifestyle factors. A trial can say what changed when the diet was assigned. A cohort cannot.
Can an anti-inflammatory diet replace medication for inflammation?
An anti-inflammatory diet cannot replace prescribed medical therapy for diagnosed inflammatory or autoimmune conditions. The clinical trials evaluating dietary patterns, including PREDIMED, studied cardiovascular risk markers in broad populations rather than treatments for clinical inflammatory diseases like rheumatoid arthritis, lupus, or Crohn's disease. Furthermore, while the CANTOS trial demonstrated that pharmaceutical inhibition of inflammation reduces cardiovascular events by 15%, dietary interventions produce distinct biomarker shifts and have not been compared directly against anti-inflammatory drugs in head-to-head clinical trials. Any modification to prescribed medications must be evaluated and managed directly by a licensed physician.